Greenbrook TMS Inc. (GBNHF)

Market Cap	1.69M
Revenue (ttm)	76.92M
Net Income (ttm)	-47.09M
Shares Out	168.64M
EPS (ttm)	-1.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,231
Average Volume	27,073
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.0080 - 0.6380
Beta	n/a
RSI	45.17
Earnings Date	Mar 28, 2025

About Greenbrook TMS

Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared neurostimulation therapy for the treatment of major depressive disorder and other mental health disorders. The company also offers Spravato, an esketamine nasal spray; and other treatment modalities for the treatment of depression and related psychiatric services. Greenbrook TMS Inc. was fo...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2011
• Employees: 489
• Stock Exchange: OTCMKTS
• Ticker Symbol: GBNHF

Financial Performance

In 2023, Greenbrook TMS's revenue was $73.79 million, an increase of 10.42% compared to the previous year's $66.83 million. Losses were -$48.91 million, -44.21% less than in 2022.